Literature DB >> 32558649

Percutaneous endobiliary forceps biopsy of biliary strictures for histopathologic examination.

Anne Marie Augustin1, Marcus Steingrüber1, Friederika Fluck1, Oliver Goetze2, Thorsten Alexander Bley1, Ralph Kickuth1.   

Abstract

PURPOSE: We aimed to investigate the feasibility, accuracy and safety of percutaneous endobiliary cholangio-forceps biopsy of biliary strictures in our institution.
METHODS: A total of 13 percutaneous transhepatic endobiliary biopsies (7 men and 6 women, mean age 66.85±16.76 years) were performed between January 2015 and March 2019 using a transluminal forceps biopsy device. Technical success, rate of complications, number of biopsy specimens, procedure and fluoroscopy time, mean radiation exposure were evaluated; sensitivity and accuracy were calculated.
RESULTS: Technical success, i.e., acquisition of at least three (median, 3.00; range, 3-5) macroscopic representative samples, could be achieved in all 13 biopsies. Access was gained via the right liver lobe in 12 of 13 cases (92.3%). All patients presented blood work indicative of cholestasis prior the intervention, with mean bilirubin 4.72±3.72 µmol/L, mean γ-glutamyl transferase 574.16 ± 360.92 IU/L, and median alkaline phosphatase 407 IU/L (165-1366 IU/L). In 12 of 13 cases (92.3%), biopsied material was sufficient for the pathologist to make a histopathologic diagnosis. Analysis revealed cases of malignancy in eight of 13 cases (61.5%), all of which turned out to be cases of cholangiocarcinoma. In four benign cases (30.8%), diagnosis was considered to be confirmed by further imaging or clinical follow-ups, which showed no signs of progressive disease. There was one case (7.7%) of a false-negative result with proof of malignancy in subsequent surgical tissue extraction. A calculation of diagnostic performance yielded a sensitivity rate of 88.9% and an accuracy rate of 92.3%. There was one case of minor and one case of major complication in our study collective, leading to an overall complication rate of 15.4%.
CONCLUSION: Percutaneous transhepatic biliary drainage (PTBD)-based forceps biopsy via the transhepatic drainage tract in patients with biliary obstruction of unknown origin is a technically feasible and safe technique with good diagnostic value rates. The procedure should be considered in patients not suitable for endoscopic strategies with indication for establishment of PTBD.

Entities:  

Mesh:

Year:  2020        PMID: 32558649      PMCID: PMC7360072          DOI: 10.5152/dir.2020.19329

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  27 in total

1.  Fluoroscopic percutaneous brush cytology, forceps biopsy and both in tandem for diagnosis of malignant biliary obstruction.

Authors:  Johannes Boos; Raphael J Yoo; Jennifer Steinkeler; Gamze Ayata; Muneeb Ahmed; Ammar Sarwar; Jeffrey Weinstein; Salomao Faintuch; Olga R Brook
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Percutaneous transhepatic biliary drainage: experience with 311 procedures.

Authors:  R W Günther; H Schild; M Thelen
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

3.  Percutaneous transluminal forceps biopsy in patients suspected of having malignant biliary obstruction: factors influencing the outcomes of 271 patients.

Authors:  Jung Gu Park; Gyoo-Sik Jung; Jong Hyouk Yun; Byung Chul Yun; Sang Uk Lee; Byung Hoon Han; Ji Ho Ko
Journal:  Eur Radiol       Date:  2017-03-27       Impact factor: 5.315

4.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J W Valle; I Borbath; S A Khan; F Huguet; T Gruenberger; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

5.  Brush and forceps biopsy of biliary ducts via percutaneous transhepatic catheterization.

Authors:  M K Elyaderani; O F Gabriele
Journal:  Radiology       Date:  1980-06       Impact factor: 11.105

6.  EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study.

Authors:  Frank Weilert; Yasser M Bhat; Kenneth F Binmoeller; Steve Kane; Ian M Jaffee; Richard E Shaw; Rees Cameron; Yusuke Hashimoto; Janak N Shah
Journal:  Gastrointest Endosc       Date:  2014-02-19       Impact factor: 9.427

7.  Fine-needle aspiration biopsy: pancreatic and biliary tumors.

Authors:  M A Hall-Craggs; W R Lees
Journal:  AJR Am J Roentgenol       Date:  1986-08       Impact factor: 3.959

8.  Percutaneous transluminal biopsy of the biliary tract.

Authors:  J J Donald; J S Fache; H J Burhenne
Journal:  Can Assoc Radiol J       Date:  1993-06       Impact factor: 2.248

Review 9.  Biliary strictures: diagnostic considerations and approach.

Authors:  Ajaypal Singh; Andres Gelrud; Banke Agarwal
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-28

10.  Histologic assessment of biliary obstruction with different percutaneous endoluminal techniques.

Authors:  Michele Rossi; Vito Cantisani; Filippo Maria Salvatori; Alberto Rebonato; Laura Greco; Luigi Giglio; Giampiero Guido; Elisa Pagliara; Vincenzo David
Journal:  BMC Med Imaging       Date:  2004-08-25       Impact factor: 1.930

View more
  5 in total

Review 1.  Systematic review and meta-analysis of percutaneous transluminal forceps biopsy for diagnosing malignant biliary strictures.

Authors:  Tae Yeon Jeon; Moon Hyung Choi; Seung Bae Yoon; Sung-Hoon Moon; Jae Seung Soh
Journal:  Eur Radiol       Date:  2021-09-18       Impact factor: 5.315

Review 2.  Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know.

Authors:  Juan C Camacho; Lynn A Brody; Anne M Covey
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 3.  Endobiliary biopsy.

Authors:  Riccardo Inchingolo; Fabrizio Acquafredda; Alessandro Posa; Thiago Franchi Nunes; Stavros Spiliopoulos; Francesco Panzera; Carlos Alberto Praticò
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

4.  Tissue sampling for biliary strictures using novel elbow biopsy forceps.

Authors:  Huahui Zhang; Chunyan Huo; Yongxin Guo; Keyuan Zhu; Fengdong Li; Jin Huang
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

5.  Percutaneous insertion of a novel dedicated metal stent to treat malignant hilar biliary obstruction.

Authors:  Francesco Cortese; Fabrizio Acquafredda; Andrea Mardighian; Maria Teresa Zurlo; Valentina Ferraro; Riccardo Memeo; Stavros Spiliopoulos; Riccardo Inchingolo
Journal:  World J Gastrointest Oncol       Date:  2022-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.